Korea

Bespin Global, named 'a Visionary' in 2022 Gartner® Magic Quadrant™ for Public Cloud IT Transformation Services

-       Only 20 companies in the world are named in this category, after the establishment of the new market last year,Bespin Global has been recognized as 'a Visionary' this year -       Bespin Global, recognized for its vision and execution -       Bespin Global named on Gartner® Magic Quadrant™...

2022-08-05 21:00 4756

Saudi Arabia to Bid for the 2026 AFC Women's Asian Cup

RIYADH, Saudi Arabia, Aug. 5, 2022 /PRNewswire/ -- The Kingdom of Saudi Arabia has officially announced its intention to bid for the 2026 AFC Women's Asian Cup. This is a landmark moment for women's football in Saudi Arabia and Asia. The bid builds on many recent developments to grow women's foo...

2022-08-05 15:33 3705

CGBio Signing a North America Out-license Contract on "Novosis rhBMP-2," a Bone Substitute with Orthofix, USA

* Embarking on a successful journey of exporting its home-grown product technology toNorth America, the largest market for bone substitutes * Enabling fast bone formation by applying bone morphogenetic protein (rhBMP-2) and next-generation synthetic carrier SEOUL, South Korea and LEWISVILLE, ...

2022-08-04 21:00 2175

Hyundai, Genesis and Kia Sweep Red Dot Awards: Brand & Communications Design 2022

* Honors include two 'Best of Best' and six 'Winner' awards * Award-winning categories include Fair Stands, Brand Stores, Showrooms, Exhibition Design, User Interface and Corporate Design Guides * Honors reflect Hyundai, Genesis and Kia's efforts to demonstrate brand values through design an...

2022-08-04 18:39 1962

ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022

-   STP0404 is the only clinical safety proven HIV treatment candidate with a novel mechanism that can block HIV re-activation. -   STP0404 is expected to enter Phase 2a clinical trial in the US in 4Q 2022. SEOUL, South Korea, Aug. 3, 2022 /PRNewswire/ -- ST Pharm Co., Ltd. (237690:KOSDAQ) annou...

2022-08-03 20:00 1740

Enfinity Global closes $242 million of long term financing for three operational solar power plants in Japan

TOKYO, Aug. 3, 2022 /PRNewswire/ -- Enfinity Global Inc, a leading renewable energy and sustainability services company, has secured$242M (¥29 billion) in long-term financing for three recently completed utility scale solar PV plants inJapan totaling 70 MW. The power plants are contracted for 18 ...

2022-08-03 20:00 2316

Jio Platforms partners with Subex HyperSense AI to augment its 5G product line

MUMBAI, India, Aug. 3, 2022 /PRNewswire/ -- Subex, a provider of Telecom Analytics Solutions and AI-led Digital Trust products to communication service providers, and Jio Platforms Limited (JPL) a leading Indian Technology Company (subsidiary of RIL [NSE: RELIANCE]), today announced a partnership...

2022-08-03 12:30 2521

Empyrion DC Announces 40MW Data Centre Project in Gangnam, Seoul

SINGAPORE, Aug. 3, 2022 /PRNewswire/ -- Empyrion DC, Asia's first green data centre developer, announced today that it is developing a 40MW green data centre in Gangnam,Seoul, South Korea ("GDC"). Empyrion DC signed a binding agreement with a local promoter to acquire 100% of the development righ...

2022-08-03 10:35 2293

Seoul Tourism Organization to host global "Conscious Travel" contest with participation of UNWTO and sponsorship of Airbnb

Sustainability, A Must for Travel SEOUL, South Korea, Aug. 3, 2022 /PRNewswire/ -- The Seoul Metropolitan Government (hereinafter SMG) and Seoul Tourism Organization (President & CEO Ki-yon Kil, hereinafter STO) announced that the Global Fair & Sustainable Travel Contest will be supported by Air...

2022-08-03 07:00 1759

LG Energy Solution Aims to Achieve RE100 in All Global Production Sites by 2025

* The initiative was introduced in the ESG Report 2021 published today * The company to focus on "Carbon Negative" after achieving carbon neutrality across the entire value chain by 2050 SEOUL, South Korea, Aug. 2, 2022 /PRNewswire/ -- LG Energy Solution (LGES; 373220) announced its plan to ac...

2022-08-03 07:00 1449

SK hynix Develops World's Highest 238-Layer 4D NAND Flash

* World's first 238-layer 512Gb TLC 4D NAND developed in July; expected to begin mass production in the first half of 2023 * Providing highest, smallest NAND product while remarkably improving productivity, data transfer speed and power efficiency * "Will continue innovations to find breakth...

2022-08-03 05:30 2382

GenKOre develops hypercompact base editing system

DAEJEON, South Korea , Aug. 2, 2022 /PRNewswire/ -- GenKOre (homepage: www.genkore.com ), a biotech start-up in Korea, had a study on the development of hypercompact adenine base editors (ABEs) published on Nature Chemical Biology onAugust 2, 2022.

2022-08-02 22:44 1940

LambdaTest's intelligent test orchestration platform HyperExecute is now available on the Microsoft Azure Marketplace

Microsoft Azure customers worldwide now gain access to HyperExecute to seamlessly orchestrate their testing and achieve a quicker go-to-market. SAN FRANCISCO, Aug. 2, 2022 /PRNewswire/ -- LambdaTest, a leading continuous quality testing cloud platform, today announced the availability of HyperEx...

2022-08-02 19:00 1995

Empyrion DC Announces 40MW Data Centre Project in Gangnam, Seoul

SINGAPORE, Aug. 2, 2022 /PRNewswire/ -- Empyrion DC, Asia's first green data centre developer, announced today that it is developing a 40MW green data centre in Gangnam,Seoul, South Korea ("GDC"). Empyrion DC signed a binding agreement with a local promoter to acquire 100% of the development righ...

2022-08-02 17:29 3760

GenKOre develops hypercompact adenine base editors (ABEs)

DAEJEON, South Korea, Aug. 2, 2022 /PRNewswire/ -- GenKOre, a biotech start-up in Korea, succeeded in the development of ABEs based on its own hypercompact gene-editing technology and had the relevant study published on Nature Chemical Biology onAugust 2, 2022.

2022-08-02 09:07 2058

New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome--Published in Clinical Cancer Research

* Recent clinical trial on combination immunotherapy for nasopharyngeal cancer provides evidence for Lunit SCOPE IO's ability to predict patient response. * Analysis indicates Immune-excluded Immune Phenotype acts as a resistance mechanism against combination immunotherapy, further supporting...

2022-08-01 21:00 1719

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

* GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities * Technology transfer and scale-up from lab bench to Samsung's commercial facility was completed in seven months * GreenLight's mRNA synthesis reaction had a titer of 12g/L at a commer...

2022-08-01 21:00 2034

Comviva and Vietnamobile announce strategic partnership to power AI-led intelligent customer engagement

Comviva MobiLytix™ Marketing Studio to deliver personalized and integrated customer experience NEW DELHI, Aug. 1, 2022 /PRNewswire/ -- Comviva , the global leader in mobility solutions, today announced i...

2022-08-01 20:35 2737

Crowdworks registers its first US patent

SEOUL, South Korea, Aug. 1, 2022 /PRNewswire/ -- Crowdworks (CEO Park Min-woo), an Artificial Intelligence (AI) training data platform company, recently announced that it had completed the registration of a US patent for 'Technology for AI target training image sampling'.

2022-08-01 20:00 1827

RCEP Economic and Trade Cooperation in 2022,injecting New Vitality into Global Economic Recovery

QINGDAO, China, July 30, 2022 /PRNewswire/ -- The year of 2022 is the first year when RCEP officially comes into effect. While standing in front of the historical opportunities that the RCEP member countries in the region opening up, developing and strengthening local economic and trade cooperati...

2022-07-30 02:09 4537
1 ... 113114115116117118119 ... 275